首页> 外文期刊>Journal of instrumentation: an IOP and SISSA journal >Tumor dosimetry for I-131 trastuzumab therapy in a Her2+ NCI N87 xenograft mouse model using the Siemens SYMBIA E gamma camera with a pinhole collimator
【24h】

Tumor dosimetry for I-131 trastuzumab therapy in a Her2+ NCI N87 xenograft mouse model using the Siemens SYMBIA E gamma camera with a pinhole collimator

机译:使用带有针孔瞄准仪的Siemens SYMBIA Eγ照相机在Her2 + NCI N87 N异种移植小鼠模型中对I-131曲妥珠单抗治疗的肿瘤剂量

获取原文
获取原文并翻译 | 示例
           

摘要

We performed imaging and therapy using I-131 trastuzumab and a pinhole collimator attached to a conventional gamma camera for human use in a mouse model. The conventional clinical gamma camera with a 2-mm radius-sized pinhole collimator was used for monitoring the animal model after administration of I-131 trastuzumab The highest and lowest radiation-received organs were osteogenic cells (0.349 mSv/MBq) and skin (0.137 mSv/MBq), respectively. The mean coefficients of variation (%CV) of the effective dose equivalent and effective dose were 0.091 and 0.093 mSv/MBq respectively. We showed the feasibility of the pinholeattached conventional gamma camera for human use for the assessment of dosimetry. Mouse dosimetry and prediction of human dosimetry could be used to provide data for the safety and efficacy of newly developed therapeutic schemes.
机译:我们使用I-131曲妥珠单抗和连接到常规γ相机的针孔准直仪进行了成像和治疗,供人类在小鼠模型中使用。施用I-131曲妥珠单抗后,使用常规的带有2 mm半径大小针孔准直器的临床伽马相机监测动物模型。最高和最低的受辐射器官是成骨细胞(0.349 mSv / MBq)和皮肤(0.137) mSv / MBq)。有效剂量当量和有效剂量的平均变异系数(%CV)分别为0.091和0.093 mSv / MBq。我们展示了带针孔的常规伽马相机用于人体剂量学评估的可行性。小鼠剂量学和人类剂量学的预测可用于为新开发的治疗方案的安全性和有效性提供数据。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号